N-(alpha-(methoxycarbonyl)benzyl)-2-phenylquinoline-4-carboxamide,
SB 218795,
SB-218795,
SB 218795,
174635-53-1,
SB-218795,
Sb218795,
CHEMBL9843,
methyl (2R)-2-phenyl-2-[(2-phenylquinoline-4-carbonyl)amino]acetate,
Methyl (2R)-phenyl{[(2-phenyl-4-quinolinyl)carbonyl]amino}acetate,
Benzeneacetic acid, alpha-(((2-phenyl-4-quinolinyl)carbonyl)amino)-, methyl ester, (alphaR)-,
Benzeneacetic acid, alpha-[[(2-phenyl-4-quinolinyl)carbonyl]amino]-, methyl ester, (alphaR)-,
SB 218795R,
Tocris-1376,
AC1O7GYW,
Lopac0_000624,
MLS000862187,
GTPL5764,
SCHEMBL4459316,
CHEBI:93066,
CTK8E8576,
HMS2231I18,
HMS3261N10,
HMS3267B22,
HMS3676K06,
ZINC601874,
Tox21_500624,
BDBM50051289,
AKOS024456559,
CCG-204712,
LP00624,
SB 218795 R,
NCGC00025131-01,
NCGC00025131-02,
NCGC00025131-03,
NCGC00025131-04,
NCGC00261309-01,
SMR000326950,
RT-015641,
EU-0100624,
S 8817,
SR-01000075910,
SR-01000597578,
J-011022,
SR-01000075910-1,
SR-01000597578-1,
BRD-K61097567-001-03-6,
(-)-(R)-N-(|A-Methoxycarbonylbenzyl)-2-phenylquinoline-4-carboxamide,
(-)-(R)-N-(alpha-Methoxycarbonylbenzyl)-2-phenylquinoline-4-carboxamide,
(R)-[[2-Phenyl-4-quinolinyl)carbonyl]amino]-methyl ester benzeneacetic acid,
(R)-Phenyl-[(2-phenyl-quinoline-4-carbonyl)-amino]-acetic acid methyl ester,
NK-3 antagonists, SB,
NK-2 antagonists, GSK,
D02CCA,
IUMQXQJZIHWLIN-HSZRJFAPSA-N,
NK-3 antagonists, GlaxoSmithKline,
C25-H20-N2-O3,
CID6604858,
GSK-172981,
GSK-256471,
SB-235375,
SB-244487,
SB-400238,
SB-414240,
SK-797230,